Close Menu

NEW YORK (GenomeWeb) – Premaitha Health said today that its Swiss customer Genoma has been placed into bankruptcy, allowing the firm to recover payments it is owed by Genoma and to sell its noninvasive prenatal Iona test to Genoma's customers.

UK-based Premaitha said Genoma owes it £750,000 ($970,000) and that it had asked the Swiss courts to place Genoma into bankruptcy for non-payment of debts. The firm said that the Swiss commercial register today confirmed the ruling in favor of Premaitha's application.  

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jan
28
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Feb
05
Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.